Sterling Pharma Solutions

New antibody-drug conjugate partnership has oncology focus
Biopharma Reporter
Wed, 12/16/20 - 10:32 pm
Sterling Pharma Solutions
CDMOs
oncology
cancer
antibody-drug conjugate